1 / 1

Acknowledgements

marlee
Télécharger la présentation

Acknowledgements

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. In candidates for assistedconception serum FSH but not oestradiol is related to declining ovarian reserve in the fourth decadeAP Brown1, L Maddison1, C Fitzgerald2, D Gould2, L Nardo2 and I Laing11Department of Clinical Biochemistry, Manchester Royal Infirmary. 2Department of Reproductive Medicine, St Mary’s Hospital, Manchester • Introduction • Reproductive performance is assumed to be determined by the decline of the primordial follicle pool in the ovary. • Criteria used to assess ovarian function and to accept subfertile patients for ovarian stimulation are still a matter of much debate. • Various biochemical and ultrasonographic markers are used to investigate the ovarian reserve in candidates for IVF. • The FSH value is critical in clinical decisions. FSH but not Oestradiol correlates with AFC • Study Details • Setting: NHS-based tertiary referral centre for reproductive medicine • FSH and Oestradiol (E2) routinely measured in IVF candidates • FSH value is critical with a current cut-off value of 10.0 IU/L • Population: 232 consecutive subfertile women undergoing day 3 hormonal and ultrasound assessment of ovarian function prior to IVF • Inclusion criteria • First ovarian stimulation treatment • Regular menstrual cycles • Both ovaries visualised by transvaginal-ultrasonography (TV-US) • No previous ovarian surgery • No hormone therapy for 6 months • No history of endocrine disorders • Age <40 years • Methods: • FSH and Oestradiol measured on a Roche E170 immunoassay system • Data analysed by Spearman’s rank correlation (r) and linear regression • FSH correlates with AFC (r = -0.28, P<0.0001, n=231) • A high FSH corresponds to a low AFC • Oestradiol (E2) shows no correlation with AFC Comparison of the 3rd and 4th decades • Aims • Relate FSH and Oestradiol levels with age • Evaluate the role of FSH and E2 in this clinical setting Characteristics of the study population • Oestradiol shows no significant difference between the age groups • FSH and AFC show statistically significant differences between the age groups FSH increases with age in the 4th decade *NB Study started before FSH cut-off was lowered to its current level of 10.0 IU/L FSH but not Oestradiol correlates with age • <30 years old group. No correlation with age (n=62) • >30 years old group. FSH correlates with age (r = 0.30, P<0.0001, n=170) • Conclusions • Oestradiol measurement does not appear to add value in this clinical setting • No correlation of FSH with age in the under 30 group in this study • Rising FSH is likely to predict declining ovarian reserve in the over 30 group • Suggests acceptance onto IVF program should be based on a reference range derived from the under 30 group • FSH correlates with age (r = 0.39, P<0.0001, n=232) • Oestradiol (E2) shows no correlation with age • Antral Follicle Count (AFC) • Independent objective predictor of ovarian reserve • Sum of follicles between 2-5mm in both ovaries determined by TV-US by experienced operators • Mean AFC 12.1 ± 6.87 SD • AFC correlates with age • (r= -0.37, P<0.0001, n=231) Acknowledgements Thanks also to Dr Allen P. Yates, Sarah Robinson and Phil Pemberton (Clinical Research Lab, MRI) and Dr Steve A. Roberts (Biostatistics Group, University of Manchester)

More Related